Following Edwards Lifesciences CEO statement on the chilly outlook for transcatheter aortic valve replacement (TAVR); James Spencer, Senior Data Scientist at GlobalData Healthcare, offers his view: “For the past couple of years, TAVR has been enjoying an explosive growth. It was one of, if not, the fastest-growing cardiovascular markets, with consistent double-digit percentage growth of […]